2011
DOI: 10.1097/prs.0b013e3182173d64
|View full text |Cite
|
Sign up to set email alerts
|

Validation of the Peripheral Trigger Point Theory of Migraine Headaches: Single-Surgeon Experience Using Botulinum Toxin and Surgical Decompression

Abstract: : Therapeutic, IV.(Figure is included in full-text article.).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

3
120
0
5

Year Published

2014
2014
2020
2020

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 127 publications
(132 citation statements)
references
References 49 publications
3
120
0
5
Order By: Relevance
“…However, extracranial trigger sites have been recently identified, and decompression of these peripheral trigger sites has been shown to have significant impact on symptomatology. [6][7][8][9][10][11][12][13] There is growing evidence within the field of neurobiology, which supports the concept of a peripheral nerve trigger in the initiation of migraine headaches. 14 A recent study also suggests, through electron microscopy and proteomic analysis, that there are biostructural differences in myelin found in peripheral nerves surgically excised from patients with migraines compared with peripheral nerves from patients without migraines (Guyuron et al, manuscript in preparation, 2014).…”
mentioning
confidence: 96%
See 1 more Smart Citation
“…However, extracranial trigger sites have been recently identified, and decompression of these peripheral trigger sites has been shown to have significant impact on symptomatology. [6][7][8][9][10][11][12][13] There is growing evidence within the field of neurobiology, which supports the concept of a peripheral nerve trigger in the initiation of migraine headaches. 14 A recent study also suggests, through electron microscopy and proteomic analysis, that there are biostructural differences in myelin found in peripheral nerves surgically excised from patients with migraines compared with peripheral nerves from patients without migraines (Guyuron et al, manuscript in preparation, 2014).…”
mentioning
confidence: 96%
“…Botulinum toxin-A (Botox) injections have been recognized and Food and Drug Administration-approved as an effective temporary preventative therapy for chronic migraine headaches, [15][16][17] and surgical decompression or neurectomy of select injection sites has been used to achieve long-term improvement of patients with diagnosed peripheral nerve compression. [6][7][8][9][10][11][12][13] …”
mentioning
confidence: 99%
“…Janis et al in a study of 24 patients found that 9.1 percent had unmasking of previously unidentified auriculotemporal pain. 15 The current literature has not isolated the specific associations between primary and secondary headache sites. This study seeks to quantify the occurrence and determine the predictors of new postoperative migraines at a secondary site.…”
mentioning
confidence: 99%
“…Classically, migraine headaches were described as a central nervous system event, but recent publications have stressed the role of peripheral nerves [4,5]. As the evidence for a peripheral explanation of migraine development continues to increase, so does the evidence for surgical decompression as an effective treatment [6][7][8][9][10][11].…”
Section: Pathophysiologymentioning
confidence: 99%